title: Reply: To PMID 25545240.
authors.affiliation: Swedish Medical Center, Seattle, WA.
authors.forename: Philip
authors.initials: P
authors.lastname: Mease
authors.affiliation: Charité Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: Joachim
authors.initials: J
authors.lastname: Sieper
authors.affiliation: Ghent University Hospital, Ghent, Belgium.
authors.forename: Filip
authors.initials: F
authors.lastname: Van den Bosch
authors.affiliation: Memorial University, St. Johns, Newfoundland, Canada.
authors.forename: Proton
authors.initials: P
authors.lastname: Rahman
authors.affiliation: AbbVie Inc., North Chicago, IL.
authors.forename: Aileen
authors.initials: A
authors.lastname: Pangan
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D025241:Spondylarthritis / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents